What to expect from GLP-1 side effects and how to manage them well. These articles cover common issues like nausea and digestion, rarer risks worth knowing, and practical steps to stay safe throughout treatment.
Side Effects & Safety
GLP-1 medications like Wegovy, Mounjaro, and Ozempic can cause a range of side effects, from mild nausea to rarer serious complications. This guide covers what to expect, how to manage common symptoms, and red flags that should prompt a call to your doctor.
GLP-1 medications like semaglutide and tirzepatide produce real results, but they also come with a range of side effects that many patients aren't fully prepared for. Real users report everything from dramatic appetite suppression to unexpected emotional shifts. This guide breaks down what the research says, what patients report, and how to manage what you experience.
A recent case of a GLP-1 medication overdose linked to a telehealth provider has raised serious questions about dosing safety and oversight. This article breaks down what went wrong, what warning signs to watch for, and how to protect yourself when using online weight-loss services. Understanding these risks could make a meaningful difference in your care.
Emerging research suggests GLP-1 medications like semaglutide may do more than help with weight loss. Scientists are now investigating whether these drugs could help prevent pulmonary fibrosis, the lung scarring that some COVID survivors develop. Here is what the current evidence shows and what it means for patients.
GLP-1 medications are best known for weight loss and blood sugar control, but new research suggests they may also reduce chronic inflammation throughout the body. This could have far-reaching implications for conditions like heart disease, arthritis, and more. Here's what the science actually says, and what it means for you right now.
Some patients on GLP-1 medications like semaglutide and tirzepatide report noticeable shifts in mood, motivation, and emotional responses. Doctors are beginning to take these reports seriously. Here's what you need to know before starting or continuing treatment.
GLP-1 medications like semaglutide and tirzepatide are showing benefits well beyond weight loss, including heart, kidney, and liver health. But these drugs also carry real risks that every patient should understand before starting. Here's what the latest evidence means for you.
Emerging research is exploring whether GLP-1 medications like semaglutide and tirzepatide could improve survival outcomes in breast cancer patients. Scientists believe the connection runs through obesity, inflammation, and insulin signaling. Here's what the early evidence shows and what it means for patients today.
